Maze Therapeutics, Inc. - MAZE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 5.4% | 2,688,520 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Third Rock Ventures IV, L.P. | 9.3% | 4,473,958 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Third Rock Ventures GP IV, L.P. | 9.3% | 4,473,958 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | TRV GP IV, LLC | 9.3% | 4,473,958 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Third Rock Ventures V, L.P. | 2.0% | 950,800 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Third Rock Ventures GP V, L.P. | 2.0% | 950,800 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | TRV GP V, LLC | 2.0% | 950,800 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences Public Fund, L.P. | 9.0% | 4,342,266 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLSP, L.P. | 9.0% | 4,342,266 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLSP, L.L.C. | 9.0% | 4,342,266 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences X, L.P. | 0.2% | 75,982 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS X, L.P. | 0.2% | 75,982 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS X, L.L.C. | 0.2% | 75,982 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences XI, L.P. | 0.3% | 149,026 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XI, L.P. | 0.3% | 149,026 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XI, L.L.C. | 0.3% | 149,026 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Frazier Life Sciences XII, L.P. | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XII, L.P. | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | FHMLS XII, L.L.C. | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | James N. Topper | 0.2% | 75,982 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Patrick J. Heron | 0.2% | 75,982 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2019, L.P. | 1.6% | 784,019 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2019 GP, L.P. | 1.6% | 784,019 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2019 GP, L.L.C. | 1.6% | 784,019 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2023, L.P. | 1.3% | 604,564 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2023 GP, L.P. | 1.3% | 604,564 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | GV 2023 GP, L.L.C. | 1.3% | 604,564 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Alphabet Holdings LLC | 2.9% | 1,388,583 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | XXVI Holdings Inc. | 2.9% | 1,388,583 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Alphabet Inc. | 2.9% | 1,388,583 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 7.3% | 3,206,472 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Foresite Capital Fund IV, L.P. | 1.2% | 522,657 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Foresite Capital Management IV, LLC | 1.2% | 522,657 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Foresite Capital Fund V, L.P. | 0.2% | 86,291 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Foresite Capital Management V, LLC | 0.2% | 86,291 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | James Tananbaum | 1.4% | 608,948 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Matrix Capital Management Company, LP | 3.5% | 1,653,684 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | DAVID E. GOEL | 3.5% | 1,653,684 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.